Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C May

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Leukemia|May 7, 2010
hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemiaA Bazeos, D Marin, A G Reid, et al.
Neurology|March 1, 2006
Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer diseaseE R Siemers, J F Quinn, J Kaye, et al.
Journal of Neurochemistry|January 9, 2001
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brainH F Dovey, V John, J P Anderson, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Leukemia|May 7, 2010
hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemiaA Bazeos, D Marin, A G Reid, et al.
Neurology|March 1, 2006
Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer diseaseE R Siemers, J F Quinn, J Kaye, et al.
Journal of Neurochemistry|January 9, 2001
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brainH F Dovey, V John, J P Anderson, et al.
Pageof 7